REPLIGEN CORP RGEN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1986-04-29
REPLIGEN CORP institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 7,568,457 | $954.1M |
| CITADEL ADVISORS LLC | 1,161,481 | $136.8M |
| Point72 Asset Management, L.P. | 569,474 | $67.1M |
| MILLENNIUM MANAGEMENT LLC | 36,461 | $4.3M |
| D. E. Shaw & Co., Inc. | 26,300 | $3.1M |
| AQR CAPITAL MANAGEMENT LLC | 8,880 | $1.0M |
Source: SEC EDGAR filings · CIK 0000730272 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.